Novo Nordisk’s acquisition of Biocorp demonstrates how insulin manufacturers are looking to take the next step in optimising insulin delivery, opening up better access to AI techniques for MDI users.
Another non-invasive CGM in a Smartwatch shows off its wares.
It turned out to be as bad as you’d expect.
Learning about step counts as an input in AID systems. What does and doesnt work, and what could be better?
Trying out a smartwatch with non-invasive glucose monitoring. This isnt the watch you’re looking for….
Using activity data to change behaviour in AID systems.
Are two hormones and an algorithm enough? Or is diabetes far more complex than that?